Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether transcutaneous electrical acustimulation (TEA) alters systemic sclerosis (SSc)-related colonic and anorectal physiology by enhancing autonomic nervous system (ANS) function. The study will examine the effects of TEA on slow colonic transit (SCT) and rectal hyposensitivity (RH), to examine whether TEA improves autonomic dysfunction and modulates inflammatory pathways.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Start Date
February 17, 2024
Primary Completion Date
August 14, 2028
Completion Date
September 1, 2029
Last Updated
June 26, 2025
60
ESTIMATED participants
Transcutaneous Electrical Acustimulation (TEA)
DEVICE
Sham-TEA
DEVICE
Lead Sponsor
The University of Texas Health Science Center, Houston
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07413341